Evidence map›Paper›PMID 37894491›Full record

ReviewMolecules (Basel, Switzerland)2023

A Review on Five and Six-Membered Heterocyclic Compounds Targeting the Penicillin-Binding Protein 2 (PBP2A) of Methicillin-Resistant

Shraddha S Ambade, Vivek Kumar Gupta, Ritesh P Bhole, Pramod B Khedekar, Rupesh V Chikhale

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Methicillin-ResistantInternational journal of molecular sciences · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2025
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Comprehensive wound healing using ETN@FeJournal of nanobiotechnology · 2025
    Article
  19. Uvarinol and Dichamanetin Derived fromPharmaceuticals (Basel, Switzerland) · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Shraddha S AmbadeDepartment of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur 440033, MH, India.
Vivek Kumar GuptaDepartment of Biochemistry, National JALMA Institute for Leprosy & Other Mycobacterial Diseases (ICMR), Agra 282004, UP, India.
Ritesh P BholeDr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune 411018, MH, India.ORCID 0000-0003-4088-7470
Pramod B KhedekarDepartment of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur 440033, MH, India.
Rupesh V ChikhaleUCL School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, UK.ORCID 0000-0001-5622-3981
Rashtrasant Tukadoji Maharaj Nagpur University · INDr. D. Y. Patil Medical College, Hospital and Research Centre · INNational JALMA Institute for Leprosy & Other Mycobacterial Diseases · INUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Methicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsHumansMethicillinMicrobial Sensitivity TestsMonobactamsPenicillin-Binding ProteinsStaphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsMethicillinMonobactamsPenicillin-Binding Proteinsheterocycleshigh-throughput screeningsmur enzymespenicillin-binding protein 2a (PBP2a)transpeptidation

Identifiers

PMID37894491
PMCPMC10609489
OpenAlexW4387502618

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.